POMDOCTOR Ltd POM

Consumer discretionary SIC 5900 - Retail-Miscellaneous Retail NAICS Retail Trade derived Nasdaq

Last close —
Market cap —
52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-3.14

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023
Revenue $57.2M——
Cost of revenue $49.7M——
Gross profit $7.5M——
R&D $1.8M——
SG&A $8.5M——
Total operating expenses $24.4M——
Operating income -$17.0M——
Pre-tax income -$18.7M——
Income tax $54——
Net income -$18.7M——
EPS, basic -3.14——
EPS, diluted -3.14——
Shares, diluted (wtd. avg.) 9.7M6.3M6.3M

Balance sheet

Fiscal year FY2025FY2024FY2023
Cash and equivalents $1.4M$1.1M—
Receivables $2.6M——
Inventory $1.2M——
Total current assets $15.0M——
Property, plant and equipment $178.3K——
Total assets $15.4M——
Accounts payable $6.4M——
Short-term debt $7.6M——
Total current liabilities $31.2M——
Long-term debt $11.7M——
Total liabilities $84.2M——
Retained earnings -$354.1M——
Total equity -$64.9M——

Cash flow

Fiscal year FY2025FY2024FY2023
Operating cash flow -$21.2M——
Depreciation and amortisation $21.4K——
Stock-based compensation $2.3M——
Capital expenditure $144.1K——
Investing cash flow -$229.9K——
Financing cash flow $22.0M——

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-056576.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -20M 0 20M 40M 60M Revenue, FY2025: 57.2M Gross profit, FY2025: 7.5M Net income, FY2025: -18.7M FY2023 FY2024 FY2025
Fiscal year FY2023FY2024FY2025
Revenue — — $57.2M
Gross profit — — $7.5M
Net income — — -$18.7M

Others in SIC 5900

TickerCompanyMarket capP/ERevenue growth
FCFS FirstCash Holdings, Inc. $7.49B 23.3x 10.7%
EZPW EZCORP INC $1.77B 20.2x 9.7%
SVV Savers Value Village, Inc. $1.44B 66.9x 9.2%
REAL TheRealReal, Inc. $1.32B — 15.4%
SPH SUBURBAN PROPANE PARTNERS LP $1.18B 10.9x 7.9%
WINA WINMARK CORP $1.00B 24.8x 5.9%
TMS Teamshares Inc $389.7M — —
PLBY Playboy, Inc. $130.6M — 4.1%